Cargando…
Screening and Identifying m6A Regulators as an Independent Prognostic Biomarker in Pancreatic Cancer Based on The Cancer Genome Atlas Database
BACKGROUND: Pancreatic cancer is one of the most malignant tumors of the digestive system, and its treatment has rarely progressed for the last two decades. Studies on m6A regulators for the past few years have seemingly provided a novel approach for malignant tumor therapy. m6A-related factors may...
Autores principales: | Lin, Bi, Pan, Yangyang, Yu, Dinglai, Dai, Shengjie, Sun, Hongwei, Chen, Shengchuan, Zhang, Jie, Xiang, Yukai, Huang, Chaohao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147537/ https://www.ncbi.nlm.nih.gov/pubmed/34055982 http://dx.doi.org/10.1155/2021/5573628 |
Ejemplares similares
-
Dermokine contributes to epithelial–mesenchymal transition through increased activation of signal transducer and activator of transcription 3 in pancreatic cancer
por: Huang, Chaohao, et al.
Publicado: (2017) -
Isoorientin induces apoptosis, decreases invasiveness, and downregulates VEGF secretion by activating AMPK signaling in pancreatic cancer cells
por: Ye, Tingting, et al.
Publicado: (2016) -
Brusatol Enhances the Chemotherapy Efficacy of Gemcitabine in Pancreatic Cancer via the Nrf2 Signalling Pathway
por: Xiang, Yukai, et al.
Publicado: (2018) -
Downregulation of TNF-α/TNF-R1 Signals by AT-Lipoxin A4 May Be a Significant Mechanism of Attenuation in SAP-Associated Lung Injury
por: Yu, Suhui, et al.
Publicado: (2019) -
Discoveries in Pancreatic Physiology and Disease Biology Using Single-Cell RNA Sequencing
por: Fu, Haotian, et al.
Publicado: (2022)